SINGAPORE, Aug 30 (Bloomberg): Rising global optimism about a coronavirus treatment is prompting a top Singapore analyst to take a bullish view of pandemic-hit small stocks in the city-state.
Newsflow related to the development of a vaccine can stoke long bets on Covid losers, according to Jarick Seet, who was ranked by the Asiamoney Brokers Poll as Singapore’s top researcher for small-cap shares in three of the last four years.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
